Menu

Filtros : "FCF" "University Suresh Gyan Vihar - School of Pharmacy, Jaipur, India" Removidos: "AREAS, JOSE ALFREDO GOMES" "Aljabali, Alaa A. A" Limpar

Filtros

Limitar por data

  • 1

1 - 3 (3 registros)

  • Artigo de periodico

    Synthesis and anticancer properties of ‘azole’ based chemotherapeutics as emerging chemical moieties: a comprehensive review (2021)

    Prasher, Parteek ; Sharma, Mousmee ; Zacconi, Flavia ; Gupt, Gaurav ; Aljabali, Alaa A ; Mishra, Vijay ; Tambuwala, Murtaza M ; Kapoor, Deepak N ; Negi, Poonam ; Pinto, Terezinha de Jesus Andreoli ; Singh, Inderbir ; Chellappan, Dinesh Kumar ; Dua, Kamal

    Fonte: Current Organic Chemistry. Unidade: FCF

    Assuntos: QUIMIOTERÁPICOS, COMPOSTOS HETEROCÍCLICOS

    Acesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      PRASHER, Parteek et al. Synthesis and anticancer properties of ‘azole’ based chemotherapeutics as emerging chemical moieties: a comprehensive review. Current Organic Chemistry, v. 25, p. 654-668, 2021Tradução . . Disponível em: https://doi.org/10.2174/1385272824999200820152501. Acesso em: 12 maio 2024.

    • APA

      Prasher, P., Sharma, M., Zacconi, F., Gupt, G., Aljabali, A. A., Mishra, V., et al. (2021). Synthesis and anticancer properties of ‘azole’ based chemotherapeutics as emerging chemical moieties: a comprehensive review. Current Organic Chemistry, 25, 654-668. doi:10.2174/1385272824999200820152501

    • NLM

      Prasher P, Sharma M, Zacconi F, Gupt G, Aljabali AA, Mishra V, Tambuwala MM, Kapoor DN, Negi P, Pinto T de JA, Singh I, Chellappan DK, Dua K. Synthesis and anticancer properties of ‘azole’ based chemotherapeutics as emerging chemical moieties: a comprehensive review [Internet]. Current Organic Chemistry. 2021 ; 25 654-668.[citado 2024 maio 12 ] Available from: https://doi.org/10.2174/1385272824999200820152501

    • Vancouver

      Prasher P, Sharma M, Zacconi F, Gupt G, Aljabali AA, Mishra V, Tambuwala MM, Kapoor DN, Negi P, Pinto T de JA, Singh I, Chellappan DK, Dua K. Synthesis and anticancer properties of ‘azole’ based chemotherapeutics as emerging chemical moieties: a comprehensive review [Internet]. Current Organic Chemistry. 2021 ; 25 654-668.[citado 2024 maio 12 ] Available from: https://doi.org/10.2174/1385272824999200820152501

  • Artigo de periodico

    Nanocarriers: more than tour de force for thymoquinone (2020)

    Rathore, Charul; Rathbone, Michael J; Chellappan, Dinesh Kumar; Tambuwala, Murtaza M ; Pinto, Terezinha de Jesus Andreoli ; Dureja, Harish; Hemrajani, Chetna; Gupta, Gaurav ; Dua, Kamal; Negi, Poonam

    Fonte: Expert Opinion on Drug Delivery. Unidade: FCF

    Assuntos: NANOPARTÍCULAS, BIODISPONIBILIDADE

    Acesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      RATHORE, Charul et al. Nanocarriers: more than tour de force for thymoquinone. Expert Opinion on Drug Delivery, v. 17, n. 4, p. 479-494, 2020Tradução . . Disponível em: https://doi.org/10.1080/17425247.2020.1730808. Acesso em: 12 maio 2024.

    • APA

      Rathore, C., Rathbone, M. J., Chellappan, D. K., Tambuwala, M. M., Pinto, T. de J. A., Dureja, H., et al. (2020). Nanocarriers: more than tour de force for thymoquinone. Expert Opinion on Drug Delivery, 17( 4), 479-494. doi:10.1080/17425247.2020.1730808

    • NLM

      Rathore C, Rathbone MJ, Chellappan DK, Tambuwala MM, Pinto T de JA, Dureja H, Hemrajani C, Gupta G, Dua K, Negi P. Nanocarriers: more than tour de force for thymoquinone [Internet]. Expert Opinion on Drug Delivery. 2020 ; 17( 4): 479-494.[citado 2024 maio 12 ] Available from: https://doi.org/10.1080/17425247.2020.1730808

    • Vancouver

      Rathore C, Rathbone MJ, Chellappan DK, Tambuwala MM, Pinto T de JA, Dureja H, Hemrajani C, Gupta G, Dua K, Negi P. Nanocarriers: more than tour de force for thymoquinone [Internet]. Expert Opinion on Drug Delivery. 2020 ; 17( 4): 479-494.[citado 2024 maio 12 ] Available from: https://doi.org/10.1080/17425247.2020.1730808

  • Artigo de periodico

    Role of the Tristetraprolin (Zinc Finger Protein 36 Homolog) Gene in Cancer (2018)

    Gupta, Gaurav; Bebawy, Mary; Pinto, Terezinha de Jesus Andreoli ; Chellappan, Dinesh Kumar; ishra, Anurag; Dua, Kamal

    Fonte: Critical Reviews in Eukaryotic Gene Expression. Unidade: FCF

    Assuntos: NEOPLASIAS, ZINCO

    Acesso à fonteDOIComo citar
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      GUPTA, Gaurav et al. Role of the Tristetraprolin (Zinc Finger Protein 36 Homolog) Gene in Cancer. Critical Reviews in Eukaryotic Gene Expression, v. 28, n. 2, p. 217-221, 2018Tradução . . Disponível em: https://doi.org/10.1615/CritRevEukaryotGeneExpr.2018021188. Acesso em: 12 maio 2024.

    • APA

      Gupta, G., Bebawy, M., Pinto, T. de J. A., Chellappan, D. K., ishra, A., & Dua, K. (2018). Role of the Tristetraprolin (Zinc Finger Protein 36 Homolog) Gene in Cancer. Critical Reviews in Eukaryotic Gene Expression, 28( 2), 217-221. doi:10.1615/CritRevEukaryotGeneExpr.2018021188

    • NLM

      Gupta G, Bebawy M, Pinto T de JA, Chellappan DK, ishra A, Dua K. Role of the Tristetraprolin (Zinc Finger Protein 36 Homolog) Gene in Cancer [Internet]. Critical Reviews in Eukaryotic Gene Expression. 2018 ; 28( 2): 217-221.[citado 2024 maio 12 ] Available from: https://doi.org/10.1615/CritRevEukaryotGeneExpr.2018021188

    • Vancouver

      Gupta G, Bebawy M, Pinto T de JA, Chellappan DK, ishra A, Dua K. Role of the Tristetraprolin (Zinc Finger Protein 36 Homolog) Gene in Cancer [Internet]. Critical Reviews in Eukaryotic Gene Expression. 2018 ; 28( 2): 217-221.[citado 2024 maio 12 ] Available from: https://doi.org/10.1615/CritRevEukaryotGeneExpr.2018021188
  • 1

1 - 3 (3 registros)

Biblioteca Digital de Produção Intelectual da Universidade de São Paulo     2012 - 2024